Literature DB >> 21762188

Effect of red maca (Lepidium meyenii) on prostate zinc levels in rats with testosterone-induced prostatic hyperplasia.

C Gonzales1, J Leiva-Revilla, J Rubio, M Gasco, G F Gonzales.   

Abstract

Lepidium meyenii (maca) is a plant that grows exclusively above 4000 m in the Peruvian central Andes. Red maca (RM) extract significantly reduced prostate size in rats with benign prostatic hyperplasia (BPH) induced by testosterone enanthate (TE). Zinc is an important regulator of prostate function. This study aimed to determine the effect of RM on prostate zinc levels in rats with BPH induced by TE. Also, the study attempted to determine the best marker for the effect of RM on sex accessory glands. Rats treated with RM extract from day 1 to day 14 reversed the effect of TE administration on prostate weight and zinc levels. However, RM administered from day 7 to day 14 did not reduce the effect of TE on all studied variables. Finasteride (FN) reduced prostate, seminal vesicle and preputial gland weights in rats treated with TE. Although RM and FN reduced prostate zinc levels, the greatest effect was observed in TE-treated rats with RM from day 1 to day 14. In addition, prostate weight and zinc levels showed the higher diagnosis values than preputial and seminal vesicle weights. In conclusion, RM administered from day 1 to day 14 reduced prostate size and zinc levels in rats where prostatic hyperplasia was induced with TE. Also, this experimental model could be used as accurately assay to determine the effect of maca obtained under different conditions and/or the effect of different products based on maca.
© 2011 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21762188     DOI: 10.1111/j.1439-0272.2011.01190.x

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  6 in total

1.  Evaluation of the Therapeutic Effect of the Traditional Herbal Medicine Atrifil and Oshagh Gum on Testosterone-Induced Benign Prostatic Hyperplasia in Wistar Rats.

Authors:  Fatemeh Akbari; Mohammad Azadbakht; Anand Gaurav; Fatemeh Azimi; Zahra Mahdizadeh; Lale Vahedi; Ayob Barzegar Nejad; Aroona Chabra; Mohammad Eghbali
Journal:  Adv Urol       Date:  2022-07-05

2.  Combining Targeted Metabolites Analysis and Transcriptomics to Reveal Chemical Composition Difference and Underlying Transcriptional Regulation in Maca (Lepidium Meyenii Walp.) Ecotypes.

Authors:  Qiansi Chen; Meng Li; Chen Wang; Zefeng Li; Jiayang Xu; Qingxia Zheng; Pingping Liu; Huina Zhou
Journal:  Genes (Basel)       Date:  2018-07-03       Impact factor: 4.096

3.  Evaluation of the effect of Lepidium meyenii Walpers in infertile patients: A randomized, double-blind, placebo-controlled trial.

Authors:  Ingrid Melnikovova; Daniela Russo; Tomas Fait; Michaela Kolarova; Jan Tauchen; Nataliya Kushniruk; Roberto Falabella; Luigi Milella; Eloy Fernández Cusimamani
Journal:  Phytother Res       Date:  2021-09-28       Impact factor: 6.388

4.  Effect of sildenafil citrate in testosterone induced benign prostate hyperplasia rat model.

Authors:  Selahattin Çalışkan; Muzaffer Oğuz Keleş; Metin İshak Öztürk; Musab Ali Kutluhan; Olgu Enis Tok; Feriha Ercan; Muhammet İhsan Karaman
Journal:  Turk J Urol       Date:  2017-12-01

5.  N-Butanol and Aqueous Fractions of Red Maca Methanolic Extract Exerts Opposite Effects on Androgen and Oestrogens Receptors (Alpha and Beta) in Rats with Testosterone-Induced Benign Prostatic Hyperplasia.

Authors:  Diego Fano; Cinthya Vásquez-Velásquez; Cynthia Gonzales-Castañeda; Emanuel Guajardo-Correa; Pedro A Orihuela; Gustavo F Gonzales
Journal:  Evid Based Complement Alternat Med       Date:  2017-12-11       Impact factor: 2.629

6.  Histoprotective Effect of Essential Oil from Citrus aurantifolia in Testosterone-Induced Benign Prostatic Hyperplasia Rat.

Authors:  Desmond O Acheampong; Isaac K Barffour; Alex Boye; Ernest A Asiamah; Francis A Armah; Christian K Adokoh; Joy F Oluyemi; Benjamin Adrah; Richard Opoku; Emmanuel Adakudugu
Journal:  Adv Urol       Date:  2019-09-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.